Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. | Sci Rep | 2022 | 36344586 | PubTator, text mining | PubMed |
| Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury. | Front Pharmacol | 2022 | 36339603 | PubTator, text mining | PubMed |
| Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma. | Front Oncol | 2022 | 36338737 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Role of epigenetic modification in interferon treatment of hepatitis B virus infection. | Front Immunol | 2022 | 36325353 | PubTator, text mining | PubMed |
| IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro. | Microbiol Spectr | 2022 | 36314949 | PubTator, text mining | PubMed |
| Meeting report: 34th international conference on antiviral research. | Antivir Chem Chemother | 2022 | 36305015 | PubTator, text mining | PubMed |
| Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review. | Front Pharmacol | 2022 | 36299895 | PubTator, text mining | PubMed |
| Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines. | Viruses | 2022 | 36298868 | PubTator, text mining | PubMed |
| Innate Immunity, Inflammation, and Intervention in HBV Infection. | Viruses | 2022 | 36298831 | PubTator, text mining | PubMed |
| Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis. | Viruses | 2022 | 36298660 | PubTator, text mining | PubMed |
| Prevalence and Genomic Sequence Analysis of Domestic Cat Hepadnavirus in the United States. | Viruses | 2022 | 36298647 | PubTator, text mining | PubMed |
| Advances in Immunotherapy for Hepatitis B. | Pathogens | 2022 | 36297173 | PubTator, text mining | PubMed |
| A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | 36292980 | PubTator, text mining | PubMed |
| Protocols of Investigation of Neonatal Cholestasis-A Critical Appraisal. | Healthcare (Basel) | 2022 | 36292464 | PubTator, text mining | PubMed |
| New Approach Methods for Hazard Identification: A Case Study with Azole Fungicides Affecting Molecular Targets Associated with the Adverse Outcome Pathway for Cholestasis. | Cells | 2022 | 36291160 | PubTator, text mining | PubMed |
| Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis. | Expert Opin Pharmacother | 2022 | 36278881 | PubTator, text mining | PubMed |
| Narrative Review: Glucocorticoids in Alcoholic Hepatitis-Benefits, Side Effects, and Mechanisms. | J Xenobiot | 2022 | 36278756 | PubTator, text mining | PubMed |
| Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress. | Front Pharmacol | 2022 | 36278209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=33